FTAI is up +138.36% since Oct ’23 pick View All Top Buy Picks
Date Action Amount Person Type
Jun 04, 2024 Buy 12 000 Cittadine Andrew Common Stock
Jun 03, 2024 Buy 12 000 Cittadine Andrew Common Stock
May 31, 2024 Buy 12 000 Cittadine Andrew Common Stock
May 30, 2024 Buy 12 000 Cittadine Andrew Common Stock
May 29, 2024 Buy 12 000 Cittadine Andrew Common Stock
May 28, 2024 Buy 84 000 Robinson Chandler Common Stock
May 28, 2024 Sell 84 000 Robinson Chandler Stock Options
May 22, 2024 Buy 25 000 Cittadine Andrew Stock Options
Mar 31, 2024 Sell 8 952 Cittadine Andrew Restricted Stock Units
Mar 31, 2024 Buy 8 952 Cittadine Andrew Common Stock
Mar 31, 2024 Sell 3 098 Cittadine Andrew Common Stock
Mar 31, 2024 Sell 9 956 Tsuchimoto Kim R Restricted Stock Units
Mar 31, 2024 Buy 9 956 Tsuchimoto Kim R Common Stock
Mar 31, 2024 Sell 4 082 Tsuchimoto Kim R Common Stock
Mar 31, 2024 Sell 24 474 Robinson Chandler Restricted Stock Units
Mar 31, 2024 Buy 24 474 Robinson Chandler Common Stock
Mar 31, 2024 Sell 7 172 Robinson Chandler Common Stock
Jan 01, 2024 Sell 6 724 Robinson Chandler Restricted Stock Units
Jan 01, 2024 Buy 6 724 Robinson Chandler Common Stock
Jan 01, 2024 Sell 2 327 Robinson Chandler Common Stock
Jan 01, 2024 Sell 1 231 Tsuchimoto Kim R Restricted Stock Units
Jan 01, 2024 Buy 1 231 Tsuchimoto Kim R Common Stock
Jan 01, 2024 Sell 505 Tsuchimoto Kim R Common Stock
Jan 01, 2024 Buy 10 000 Rioux Patrice Stock Options
Dec 31, 2023 Buy 2 533 Anderson Raymond Common Stock
Dec 31, 2023 Sell 2 533 Anderson Raymond Restricted Stock Units
Dec 31, 2023 Buy 2 533 Brown Michael J Common Stock
Dec 31, 2023 Sell 2 533 Brown Michael J Restricted Stock Units
Dec 31, 2023 Sell 8 952 Cittadine Andrew Restricted Stock Units
Dec 31, 2023 Buy 8 952 Cittadine Andrew Common Stock
Dec 31, 2023 Sell 3 098 Cittadine Andrew Common Stock
Dec 31, 2023 Buy 2 533 Klausner Arthur J Common Stock
Dec 31, 2023 Sell 2 533 Klausner Arthur J Restricted Stock Units
Dec 31, 2023 Buy 2 533 Starr Christopher M Common Stock
Dec 31, 2023 Sell 2 533 Starr Christopher M Restricted Stock Units
Dec 31, 2023 Sell 24 474 Robinson Chandler Restricted Stock Units
Dec 31, 2023 Buy 24 474 Robinson Chandler Common Stock
Dec 31, 2023 Sell 8 469 Robinson Chandler Common Stock
Dec 31, 2023 Sell 9 957 Tsuchimoto Kim R Restricted Stock Units
Dec 31, 2023 Buy 9 957 Tsuchimoto Kim R Common Stock
Dec 31, 2023 Sell 4 073 Tsuchimoto Kim R Common Stock
Sep 30, 2023 Sell 24 474 Robinson Chandler Restricted Stock Units
Sep 30, 2023 Buy 24 474 Robinson Chandler Common Stock
Sep 30, 2023 Sell 7 172 Robinson Chandler Common Stock
Sep 30, 2023 Sell 9 956 Tsuchimoto Kim R Restricted Stock Units
Sep 30, 2023 Buy 9 956 Tsuchimoto Kim R Common Stock
Sep 30, 2023 Sell 3 444 Tsuchimoto Kim R Common Stock
Sep 30, 2023 Buy 2 533 Starr Christopher M Common Stock
Sep 30, 2023 Sell 2 533 Starr Christopher M Restricted Stock Units
Sep 30, 2023 Buy 2 533 Klausner Arthur J Common Stock
Sep 30, 2023 Sell 2 533 Klausner Arthur J Restricted Stock Units
Sep 30, 2023 Buy 2 533 Brown Michael J Common Stock
Sep 30, 2023 Sell 2 533 Brown Michael J Restricted Stock Units
Sep 30, 2023 Buy 2 533 Anderson Raymond Common Stock
Sep 30, 2023 Sell 2 533 Anderson Raymond Restricted Stock Units
Sep 30, 2023 Sell 8 953 Cittadine Andrew Restricted Stock Units
Sep 30, 2023 Buy 8 953 Cittadine Andrew Common Stock
Sep 30, 2023 Sell 2 624 Cittadine Andrew Common Stock
Jun 30, 2023 Sell 13 841 Cittadine Andrew Restricted Stock Units
Jun 30, 2023 Buy 13 841 Cittadine Andrew Common Stock
Jun 30, 2023 Sell 4 057 Cittadine Andrew Common Stock
Jun 30, 2023 Buy 2 534 Anderson Raymond Common Stock
Jun 30, 2023 Sell 2 534 Anderson Raymond Restricted Stock Units
Jun 30, 2023 Buy 2 534 Brown Michael J Common Stock
Jun 30, 2023 Sell 2 534 Brown Michael J Restricted Stock Units
Jun 30, 2023 Buy 2 534 Klausner Arthur J Common Stock
Jun 30, 2023 Sell 2 534 Klausner Arthur J Restricted Stock Units
Jun 30, 2023 Buy 2 534 Starr Christopher M Common Stock
Jun 30, 2023 Sell 2 534 Starr Christopher M Restricted Stock Units
Jun 30, 2023 Sell 14 846 Tsuchimoto Kim R Restricted Stock Units
Jun 30, 2023 Buy 14 846 Tsuchimoto Kim R Common Stock
Jun 30, 2023 Sell 5 104 Tsuchimoto Kim R Common Stock
Jun 30, 2023 Sell 35 039 Robinson Chandler Restricted Stock Units
Jun 30, 2023 Buy 35 039 Robinson Chandler Common Stock
Jun 30, 2023 Sell 10 269 Robinson Chandler Common Stock
Mar 31, 2023 Buy 2 533 Starr Christopher M Common Stock
Mar 31, 2023 Sell 2 533 Starr Christopher M Restricted Stock Units
Mar 31, 2023 Buy 2 533 Klausner Arthur J Common Stock
Mar 31, 2023 Sell 2 533 Klausner Arthur J Restricted Stock Units
Mar 31, 2023 Buy 2 533 Brown Michael J Common Stock
Mar 31, 2023 Sell 2 533 Brown Michael J Restricted Stock Units
Mar 31, 2023 Buy 2 533 Anderson Raymond Common Stock
Mar 31, 2023 Sell 2 533 Anderson Raymond Restricted Stock Units
Mar 31, 2023 Sell 13 911 Robinson Chandler Restricted Stock Units
Mar 31, 2023 Buy 13 911 Robinson Chandler Common Stock
Mar 31, 2023 Sell 4 286 Robinson Chandler Common Stock
Mar 31, 2023 Sell 5 067 Tsuchimoto Kim R Restricted Stock Units
Mar 31, 2023 Buy 5 067 Tsuchimoto Kim R Common Stock
Mar 31, 2023 Sell 1 842 Tsuchimoto Kim R Common Stock
Mar 31, 2023 Sell 4 063 Cittadine Andrew Restricted Stock Units
Mar 31, 2023 Buy 4 063 Cittadine Andrew Common Stock
Mar 31, 2023 Sell 1 154 Cittadine Andrew Common Stock
Feb 01, 2023 Buy 13 930 Anderson Raymond Stock Options
Feb 01, 2023 Buy 10 133 Anderson Raymond Restricted Stock Units
Feb 01, 2023 Buy 13 930 Brown Michael J Stock Options
Feb 01, 2023 Buy 10 133 Brown Michael J Restricted Stock Units
Feb 01, 2023 Buy 169 012 Robinson Chandler Restricted Stock Units
Feb 01, 2023 Buy 221 839 Robinson Chandler Stock Options
Feb 01, 2023 Buy 13 930 Klausner Arthur J Stock Options
Feb 01, 2023 Buy 10 133 Klausner Arthur J Restricted Stock Units
INSIDER POWER
24.349
Last 100 transactions
Buy: 907 442 | Sell: 422 178 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 24.349.

In total, the insiders bought 907 442 and sold 422 178 MNPR shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Monopar Therapeutics Inc.

Monopar Therapeutics. Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe oral mucositis in patients with oropharyngeal cancer. The company also engages in developing Camsirubic... MNPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT